SEC 13F Intelligence

Canada Life Assurance Co / ABT

Canada Life Assurance Co’s Abbott Laboratories Position

Does Canada Life Assurance Co own Abbott Laboratories (ABT)? Yes — 1.87M shares worth $192M (+0.34% of its 13F portfolio) as of Q1 2026, down from 1.87M shares the prior filed quarter.

Position Value
$192M
Q1 2026
Shares
1.87M
% of Portfolio
+0.34%
Quarters Held
28
currently held

Position History ABT

Reported value by quarter
Q2 ’19: $135MQ2 ’19Q3 ’19: $131MQ4 ’19: $140MQ1 ’20: $125MQ2 ’20: $137MQ2 ’20Q3 ’20: $163MQ4 ’20: $166MQ1 ’21: $178MQ2 ’21: $164MQ2 ’21Q3 ’21: $164MQ4 ’21: $202MQ1 ’22: $176MQ2 ’22: $153MQ2 ’22Q3 ’22: $132MQ4 ’22: $152MQ1 ’23: $141MQ2 ’23: $150MQ2 ’23Q3 ’23: $132MQ4 ’23: $166MQ1 ’24: $133MQ2 ’24: $136MQ2 ’24Q3 ’24: $155MQ4 ’24: $177MQ1 ’25: $240MQ2 ’25: $262MQ2 ’25Q3 ’25: $292MQ4 ’25: $235MQ1 ’26: $192Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.87M$192M+0.34%
Q4 20251.87M$235M+0.41%
Q3 20252.19M$292M+0.42%
Q2 20251.93M$262M+0.42%
Q1 20251.81M$240M+0.42%
Q4 20241.57M$177M+0.31%
Q3 20241.36M$155M+0.27%
Q2 20241.31M$136M+0.26%
Q1 20241.17M$133M+0.27%
Q4 20231.51M$166M+0.36%
Q3 20231.36M$132M+0.32%
Q2 20231.36M$150M+0.35%
Q1 20231.39M$141M+0.35%
Q4 20221.38M$152M+0.40%
Q3 20221.36M$132M+0.38%
Q2 20221.41M$153M+0.40%
Q1 20221.41M$176M+0.37%
Q4 20211.44M$202M+0.42%
Q3 20211.38M$164M+0.38%
Q2 20211.41M$164M+0.37%
Q1 20211.49M$178M+0.43%
Q4 20201.52M$166M+0.31%
Q3 20201.50M$163M+0.35%
Q2 20201.51M$137M+0.32%
Q1 20201.57M$125M+0.33%
Q4 20191.62M$140M+0.30%
Q3 20191.57M$131M+0.31%
Q2 20191.61M$135M+0.31%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Canada Life Assurance Co’s full portfolio or all institutional holders of ABT.